T1	Participants 427 505	Patients who had symptomatic atrial fibrillation for > 48 hours but < 6 months
T2	Participants 748 892	Patients who were in sinus rhythm spontaneously or had sinus rhythm restored by electric cardioversion on day 4 were discharged from the hospita
T3	Participants 1223 1246	A total of 446 patients
T4	Participants 1277 1331	314 were in the subgroup with structural heart disease
T5	Participants 1607 1674	There was 1 death in the placebo group and 3 in the azimilide group
